National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 5920-5921 [2024-01776]

Download as PDF 5920 Federal Register / Vol. 89, No. 20 / Tuesday, January 30, 2024 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Literature Selection Technical Review Committee, February 22, 2024, 8 a.m. to 4 p.m. and February 23, 2024, 10 a.m. to 4 p.m., which was published in the Federal Register on December 21, 2023, 88 FR 244, Page 88404. This meeting will be amended to change the meeting times to 10 a.m. to 4 p.m. for both days. The entire meeting will be closed to the public, other than an open session on February 22, 2024 from 1:30 p.m. to 1:50 p.m. The open session of the meeting will be virtual. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice no later than 7 days prior to the meeting. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify Dianne Babski, Associate Director, Division of Library Operations, National Library of Medicine at babskid@mail.nih.gov. The open session will be videocast and can be accessed from the NIH Videocast website at https://videocast.nih.gov/. Name of Committee: National Institute on Aging Special Emphasis Panel; Aging Hormone Study. Date: March 19, 2024. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ramesh Vemuri, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, 7201 Wisconsin Avenue, Gateway Bldg., Suite 2C212, Bethesda, MD 20892, 301–402–7700, rv23r@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: January 25, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–01820 Filed 1–29–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meetings National Institute on Aging; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; NIEHS Support for Conferences and Scientific Meetings. Date: February 28, 2024. Time: 11:00 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Sciences, Keystone Building, 530 Davis Drive, Durham, NC 27709 (Virtual Meeting). Contact Person: Alfonso R. Latoni, Ph.D., Senior Advisor to the Director and Scientific Dated: January 25, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–01825 Filed 1–29–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health khammond on DSKJM1Z7X2PROD with NOTICES and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Sep<11>2014 17:23 Jan 29, 2024 Jkt 262001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Review Officer, Office of the Division Director, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, (984) 287–3279, alfonso.latoni@nih.gov. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; External In Vivo & In Vitro Toxicological Evaluation within the Division of Translational Toxicology (DTT). Date: February 29, 2024. Time: 10:30 a.m. to 6:00 p.m. Agenda: To review and evaluate contract proposals, Place: National Institute of Environmental Health Sciences, Keystone Building, 530 Davis Drive, Durham, NC 27709 (Virtual Meeting), Contact Person: Leroy Worth, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Sciences, P.O. Box 12233, MD EC–30/ Room 3171, Research Triangle Park, NC 27709, 984–287–3340, worth@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: January 25, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–01823 Filed 1–29–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\30JAN1.SGM 30JAN1 Federal Register / Vol. 89, No. 20 / Tuesday, January 30, 2024 / Notices Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; HHS–NIH–CDC–SBIR PHS 2024–1 Phase I and Phase II: Adjuvant Discovery and Down-Selection for Vaccines against Infectious and Immune-Mediated Diseases (Topic 130). Date: February 23, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31B, Rockville, MD 20892 (Video Assisted Meeting). Contact Person: James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G31B, Rockville, MD 20892, (240) 669–5060, james.snyder@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 24, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–01776 Filed 1–29–24; 8:45 am] Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Sushmita Purkayastha, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Room 814, Bethesda, MD 20817, sushmita.purkayastha@nih.gov. Name of Committee: Arthritis and Musculoskeletal and Skin Diseases Initial Review Group; Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section. Date: February 29–March 1, 2024. Time: 9:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Yasuko Furumoto, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 6701 Democracy Boulevard, Room 820, Bethesda, MD 30892, 301–827–7835, yasuko.furumoto@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: January 25, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2024–01813 Filed 1–29–24; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings DEPARTMENT OF HOMELAND SECURITY [Docket Number DHS–2023–0017] khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Arthritis and Musculoskeletal and Skin Diseases Initial Review Group; Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section. Date: February 22–23, 2024. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 17:23 Jan 29, 2024 Jkt 262001 Agency Information Collection Activities: USSS Citizens Academy Application, Electronic Form Department of Homeland Security (DHS). ACTION: 30-Day notice and request for comments. AGENCY: The Department of Homeland Security will submit the following Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. DHS Previously published this ICR in the Federal Register on Friday, November 17, 2023 for a 60-day public comment period. There was one comment received by DHS. The purpose of this notice is to allow additional 30-days for public comments DATES: Comments are encouraged and will be accepted until February 29, SUMMARY: PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 5921 2024. This process is conducted in accordance with 5 CFR 1320.1. ADDRESSES: You may submit comments, identified by docket number Docket #DHS–2023–0017, at: Æ Federal eRulemaking Portal: https://www.regulations.gov. Please follow the instructions for submitting comments. Instructions: All submissions received must include the agency name and docket number Docket #DHS–2023– 0017. All comments received will be posted without change to https:// www.regulations.gov, including any personal information provided. Docket: For access to the docket to read background documents or comments received, go to https:// www.regulations.gov. The Agency has initiated a Citizens Academy to inform the public about its mission, focused on participation from local community leaders. The academy will take place in local Agency field offices. Prior to participating, applicants will need to provide information as their community leadership role and provide PII so that a background investigation can be conducted to check for criminal history, open warrants, etc. The application allows for the Agency to gather the information necessary for each applicant to determine if they are eligible for participation. Authority to collect the information sought on this form is derived from Title 28 U.S.C. 599A, 28 CFR 0.130, and 18 U.S.C. 3056. This will be a new collection of information. The Agency has initiated a Citizens Academy for local community members, who will need to fill out an application to express interest and to provide PII for the Agency to initiate a background investigation for the applicants prior to participating in the USSS Citizens Academy. The information will be gathered by electronic submission of the USSS Citizens Academy Application to local Agency Field Offices. Applicant information will also be used to contact any applicants placed on a wait list to join future USSS Citizens Academies. All information collected will be via electronic submission. The applicant will receive a PDF form via email to complete and submit to the agency. All respondents are individuals, not small businesses/entities. The collection will only occur one time per year upon initial application to the Agency requesting to participate in the USSS Citizens Academy. There would be no way to reduce the frequency or else community members SUPPLEMENTARY INFORMATION: E:\FR\FM\30JAN1.SGM 30JAN1

Agencies

[Federal Register Volume 89, Number 20 (Tuesday, January 30, 2024)]
[Notices]
[Pages 5920-5921]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01776]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.


[[Page 5921]]


    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2024-1 Phase I 
and Phase II: Adjuvant Discovery and Down-Selection for Vaccines 
against Infectious and Immune-Mediated Diseases (Topic 130).
    Date: February 23, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G31B, 
Rockville, MD 20892 (Video Assisted Meeting).
    Contact Person: James T. Snyder, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G31B, 
Rockville, MD 20892, (240) 669-5060, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 24, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01776 Filed 1-29-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.